Document:

Form of Change in Control Agreement

 Exhibit 10.1 
 CHANGE IN CONTROL AGREEMENT 
 Agreement made as of the
     day of                 , 201    , by and between Gentiva Health Services, Inc., a Delaware corporation
(the “Company”), and                              (the “Executive”). 

WHEREAS, the Executive is a key employee of the Company; and 
 WHEREAS, the Board of Directors of the Company (the “Board”) considers the maintenance of a sound management to be essential to protecting and enhancing the best interests of the Company and its
stockholders and recognizes that the possibility of a change in control raises uncertainty and questions among key employees and may result in the departure or distraction of such key employees to the detriment of the Company and its stockholders;
and 
 WHEREAS, the Board wishes to assure that it will have the continued dedication of the Executive and the availability of
his or her advice and counsel, notwithstanding the possibility, threat or occurrence of a bid to take over control of the Company, and to induce the Executive to remain in the employ of the Company; and 

WHEREAS, the Executive and the Company previously entered into a Change in Control Agreement dated
                            , which is scheduled to terminate on February 26, 2011; and

 WHEREAS, the Executive and the Company wish to enter into a new Change in Control Agreement as set forth herein; and

 WHEREAS, the Executive is willing to continue to serve the Company taking into account the provisions of this Agreement;

 NOW, THEREFORE, in consideration of the foregoing, and the respective covenants and agreements of the parties herein
contained, the parties agree as follows: 
 1. Operation and Term of Agreement. This Agreement shall commence as of the
date first set forth above and shall terminate on February 26, 2014 unless this Agreement is terminated earlier as set forth below; provided, however, that after a Change in Control of the Company during the term of this Agreement, this
Agreement shall remain in effect until all of the obligations of the parties hereunder are satisfied and the Protection Period has expired. Notwithstanding the foregoing, prior to a Change in Control this Agreement shall immediately terminate upon
termination of the Executive’s employment, except in the case of such termination under circumstances set forth in the last paragraph of Section 4 below. 
 2. Change in Control; Protection Period. A “Change in Control” shall be deemed to occur on the date that any of the following events occur: 

(a) any person or persons acting together which would constitute a “group” for purposes of Section 13(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) (other than the Company or any subsidiary) shall beneficially own (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, at least 25% of the total voting power of all
classes of capital stock of the Company entitled to vote generally in the election of the Board; 

 (b) either (i) Current Directors (as herein defined) shall cease for any reason to
constitute at least a majority of the members of the Board (for these purposes, a “Current Director” shall mean any member of the Board as of the date set forth in the first paragraph of this Agreement, and any successor of a Current
Director whose election or nomination for election by the Company’s shareholders, was approved by at least two-thirds of the Current Directors then on the Board) or (ii) at any meeting of the shareholders of the Company called for the
purpose of electing directors, a majority of the persons nominated by the Board for election as directors shall fail to be elected; 
 (c) consummation of (i) a plan of complete liquidation of the Company, or (ii) a merger or consolidation of the Company (A) in which the Company is not the continuing or surviving
corporation (other than a consolidation or merger with a wholly owned subsidiary of the Company in which all shares of common stock of the Company (the “Common Stock”) outstanding immediately prior to the effectiveness thereof are changed
into common stock of the subsidiary) or (B) pursuant to which the Common Stock is converted into cash, securities or other property, except a consolidation or merger of the Company in which the holders of the Common Stock immediately prior to
the consolidation or merger have, directly or indirectly, at least a majority of the common stock of the continuing or surviving corporation immediately after such consolidation or merger or in which the Board immediately prior to the merger or
consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of the continuing or surviving corporation; or 
 (d) consummation of a sale or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of the Company. 

A “Protection Period” shall be the period beginning on the date of a Change in Control and ending on the second anniversary of
the date on which the Change in Control occurs. 
 3. Termination Following Change in Control. The Executive shall be
entitled to the benefits provided in Section 4 hereof upon any termination of his or her employment with the Company within a Protection Period, except a termination of employment (a) because of his or her death; (b) because of a
“Disability;” (c) by the Company for “Cause;” or (d) by the Executive other than for “Good Reason.” 
 (i) Disability. The Executive’s employment shall be deemed to have terminated because of a “Disability” if the Executive applies for and is determined to be eligible to receive
disability benefits under the Company’s long-term disability plan or program, or, in the absence of such a plan or program, as defined in Section 22 of the Internal Revenue Code of 1986, as amended (the “Code”). 

  
 2 

 (ii) Cause. Termination by the Company of the Executive’s employment for
“Cause” shall mean termination due to (A) the Executive’s conviction of a felony, (B) any act of willful fraud, dishonesty or moral turpitude, (C) the willful and continued failure by the Executive to substantially
perform his or her duties with the Company, after a written demand for substantial performance is delivered to the Executive by the Board which specifically identifies the manner in which the Board believes that the Executive has not substantially
performed his or her duties, or (D) the willful engaging by the Executive in conduct which is demonstrably and materially injurious to the Company, monetarily or otherwise. For purposes hereof, no act, or failure to act, on the Executive’s
part shall be considered “willful” unless done, or omitted to be done, by the Executive without reasonable belief that his or her action or omission was in the best interest of the Company. Notwithstanding the foregoing, the Executive
shall not be deemed to have been terminated for Cause unless and until there shall have been delivered to the Executive a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the entire membership of the Board at
a meeting of the Board called and held for that purpose (after reasonable notice to the Executive and an opportunity for the Executive, together with his or her counsel, to be heard before the Board), finding that in the good faith opinion of the
Board the Executive engaged in the prohibited conduct set forth above in the first sentence of this subsection and specifying the particulars thereof in detail. 
 (iii) Without Cause. The Company may terminate the employment of the Executive without Cause during a Protection Period only by giving the Executive written notice of termination to that effect. In
that event, the Executive’s employment shall terminate on the last day of the month in which such notice is given (or such later date as may be specified in such notice), and the benefits set forth in Section 4 hereof shall be provided to
the Executive. 
 (iv) Good Reason. For purposes hereof, “Good Reason” shall mean, unless remedied by the
Company within thirty (30) days after the receipt of written notice from the Executive as provided below or consented to in writing by the Executive: 
 (A) a material reduction by the Company in the Executive’s annual base salary (other than any reduction therein which is in proportion to reductions in the base salaries of all of the Company’s
executive officers, unless, however, such proportionate reduction exceeds 20% of the Executive’s annual base salary); 
 (B) the Company has required the Executive to be relocated anywhere in excess of forty (40) miles farther from the Executive’s principal residence than was the Executive’s office location
immediately before the beginning of the Protection Period, except for required travel on the business of the Company; 
 (C) there has occurred a failure by the Company to maintain plans providing benefits not materially less favorable, when considered in the aggregate, than those provided by any benefit or compensation
plan (including, without limitation, any incentive compensation plan, bonus plan or program, retirement, pension or savings plan, stock option plan, restricted stock plan, life insurance plan, health and dental plan and disability plan) in which the
Executive 

  
 3 

 
is participating immediately before the beginning of the Protection Period, or the Company has taken any action which would adversely affect the Executive’s participation in or reduce the
Executive’s benefits (other than stock option, restricted stock, performance share unit or performance cash award grants) under any such plans in the aggregate or deprive the Executive of any material fringe benefit in the aggregate enjoyed by
the Executive immediately before the beginning of the Protection Period, or the Company has failed to provide the Executive with the number of paid vacation days to which he or she would be entitled in accordance with the normal vacation policy of
the Company as in effect immediately before the beginning of the Protection Period; provided, however, that a reduction in benefits under the Company’s tax-qualified retirement, pension or savings plans or its life insurance plan, health
and dental plan, disability plans or other insurance plans which reduction applies equally to all participants in the plans and has a less than 10% effect on the aggregate benefits of the Executive under such plans shall not constitute “Good
Reason” for termination by the Executive; 
 (D) there has occurred the assignment to the Executive of any
material duties inconsistent with his or her status as a senior executive officer of the Company or a material diminution in the Executive’s authority, duties or responsibilities from those in effect immediately prior to the Change in Control;

 (E) the Company has failed to obtain the assumption of the obligations contained in this Agreement by any
successor as contemplated in Section 9(c) hereof; or 
 (F) there occurs any purported termination of the
Executive’s employment by the Company for Cause or without Cause which is not effected pursuant to a written notice of termination as described in subsection (ii) or (iii) above. 

The Executive shall exercise his or her right to terminate employment for Good Reason by giving the Company written notice of termination
specifying in reasonable detail the circumstances constituting such Good Reason within ninety (90) days of the initial existence of the Good Reason condition, and the Company will have a period of thirty (30) days from receipt of such
written notice during which it may remedy the condition. In the event the Company fails to remedy the condition within such period, the Executive’s employment shall terminate immediately following the end of such period. 

A termination of employment by the Executive within a Protection Period shall be for Good Reason if one of the occurrences specified in
this subsection (iv) shall have occurred, notwithstanding that the Executive may have other reasons for terminating employment, including employment by another employer which the Executive desires to accept. 

4. Benefits Upon Termination Within Protection Period. If, within a Protection Period, the Executive’s employment by the
Company shall be terminated (a) by the Company without Cause and not due to the Executive’s death or Disability, or (b) by the 

  
 4 

 
Executive for Good Reason, the Executive shall be entitled to severance benefits provided for below (and the Executive shall not be entitled to severance benefits otherwise payable under the
Executive’s separate severance agreement with the Company or under any other severance plan or policy of the Company): 
 (i) The Company shall pay to the Executive (A) base salary at the rate then in effect through the date of the Executive’s termination of employment in accordance with the standard payroll
practices of the Company, and (B) base salary in lieu of any unused paid time off (“PTO”) in accordance with the Company’s general PTO policy, which shall be paid, subject to Section 10 below, ten (10) business days
after the date of such termination of employment; 
 (ii) The Company shall pay to the Executive an amount in
cash equal to two times the sum of (A) the Executive’s annual base salary in effect immediately prior to the date of the Executive’s termination of employment or the date of the Change in Control (whichever is higher), and
(B) the higher of (x) the Executive’s target annual bonus for the year that includes the date of the Executive’s termination of employment or (y) the annual bonus of the Executive averaged for the three years immediately
prior to the year that includes the date of the Executive’s termination of employment; and such amount shall be paid, subject to Section 10 below, in a lump sum ten (10) business days after the date of such termination of employment;

 (iii) The Executive shall be entitled to a pro rata share of the target annual bonus for the year that
includes the date of the Executive’s termination of employment based on the portion of such year that the Executive was employed by the Company, which shall be paid, subject to Section 10 below, in a lump sum ten (10) business days
after the date of such termination of employment; 
 (iv) The Company shall continue to cover the Executive and
his or her dependents under, or provide the Executive and his or her dependents with insurance coverage no less favorable than, the Company’s life, disability, health, dental or other employee welfare benefit plans or programs (as in effect on
the day immediately preceding the Protection Period or on the date of termination of his or her employment, whichever is more favorable to the Executive) for a period equal to the lesser of (x) two years following the date of termination or
(y) until the Executive is provided by another employer with benefits substantially comparable to the benefits provided by such plans or programs, provided, however, that the provision of this benefit shall be contingent upon the
cooperation of the Executive (or his or her dependent, as applicable) in any reasonable request by the Company to facilitate the provision of such benefit, including responding to questionnaires and submitting to minimally intrusive medical
examinations; 
 (v) All options to purchase Company stock held by the Executive and all restricted shares of
Company stock, restricted Company share units, performance share units, performance cash awards and other equity-based compensation awards held by the Executive shall become immediately vested in full upon such termination of employment, and all
such stock options shall be exercisable for the longer of (x) one year 

  
 5 

 
following such termination of employment (but not beyond the original full term of the award) or (y) such period of time as may be provided for in the plan under which such awards were
granted; 
 (vi) All of the Executive’s benefits accrued under the pension, retirement, savings and deferred
compensation plans of the Company shall become vested in full; provided, however, that to the extent such accelerated vesting or benefits cannot be provided under one or more of such plans consistent with applicable provisions of the Code,
such benefits shall be paid to the Executive outside the applicable plan in a lump sum, subject to Section 10 below, ten (10) business days after the date of termination of employment; provided, further, however, that, to the extent
any such unvested benefit constitutes deferred compensation for purposes of Section 409A of the Code, the payment of such deferred compensation shall instead be made at the time it was otherwise scheduled to be paid under the applicable plan;
and 
 (vii) The Executive shall be entitled to outplacement services with an outplacement firm of the
Executive’s choice for up to twelve (12) months or until the Executive obtains comparable employment (as determined by the Company), whichever is shorter; provided, however, that (i) the Executive must select an outplacement
firm and commence the outplacement services no more than ninety (90) days following the Executive’s termination of employment, (ii) such outplacement services must be reasonable and commensurate with the Executive’s position with
the Company (as determined by the Company), and (iii) in no event, shall the aggregate amount the Company incurs to provide such outplacement services exceed more than thirty thousand dollars ($30,000). 

Notwithstanding anything in this Agreement to the contrary, in the event the Executive’s employment with the Company is terminated
by the Company (other than for Cause) within the one year period before the date on which a Change in Control occurs, and it is reasonably demonstrated that such termination (i) was at the request of a third party who has taken steps reasonably
calculated or intended to effect a Change in Control or (ii) otherwise arose in connection with or in anticipation of a Change in Control, the Executive shall be entitled to the benefits described in this Section 4 above, except as
otherwise modified in this paragraph. In such event, amounts will be payable hereunder only following, and, subject to Section 10 below, ten (10) business days after, the Change in Control; provided, however, that, to the extent any
such benefits constitute deferred compensation for purposes of Section 409A of the Code and were payable in connection with the Executive’s termination of employment, the payment of such deferred compensation shall instead be made at the
time the benefits were otherwise scheduled to be paid in connection with the Executive’s termination of employment. Any amount so payable hereunder shall be reduced by the amount of severance benefits paid or payable to the Executive under any
other severance agreement or plan of the Company. In addition, with respect to the benefits described in subsection (v) (certain equity and incentive awards), to the extent any unvested awards as of the date of the Executive’s termination
of employment expired or were otherwise terminated without any compensation paid in lieu thereof, the Executive shall receive an additional payment equal to the fair market value of such awards (as determined in good faith by the Company) as of the
date of the Change in Control or, if earlier, the expiration of the original full term of the award as if such awards remained 

  
 6 

 
outstanding through such date. The additional payment shall be made, subject to Section 10 below, ten (10) business days after the Change in Control. No other benefits shall be provided
under this paragraph with respect to the awards described in subsection (v). 
 5. Non-exclusivity of Rights. Except as
expressly set forth herein, this Agreement shall not prevent or limit the Executive’s continuing or future participation in any benefit, bonus, incentive or other plans, practices, policies or programs provided by the Company or any of its
subsidiaries and for which the Executive may qualify, nor shall it limit or otherwise affect such rights as the Executive may have under any stock option or other agreements with the Company or any of its subsidiaries. Amounts which are vested
benefits or which the Executive is otherwise entitled to receive under any plan, practice, policy or program of the Company or any of its subsidiaries at or subsequent to the date of termination of the Executive’s employment shall be payable in
accordance with such plan, practice, policy or program. 
 6. Full-Settlement; Legal Expenses. The Company’s
obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have
against the Executive or others. In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement. The Company
agrees to pay all legal fees and expenses which the Executive may reasonably incur as a result of any dispute or contest by or with the Company or others regarding the validity or enforceability of, or liability under, any provision of this
Agreement (including as a result of any contest by the Executive about the amount of any payment hereunder) if the Executive substantially prevails in the dispute or contest. Following the final determination of the dispute in which the Executive
has substantially prevailed, the Company shall reimburse all such reasonable costs within ten (10) days following written demand therefor (supported by documentation of such costs) by the Executive, and the Executive shall make such written
demand within sixty (60) days following the final determination of the dispute; provided, however, that such payment shall be made no later than on or prior to the end of the calendar year following the calendar year in which the cost is
incurred. Notwithstanding the foregoing, in the event a final determination or the dispute has not been made by December 20 of the year following the calendar year in which the cost is incurred, the Company shall, within ten (10) days
after such December 20, reimburse such reasonable costs (supported by documentation of such costs) incurred in the prior taxable year; provided, however, that the Executive shall return such amounts to the Company within ten
(10) business days following the final determination if the Executive did not substantially prevail in the dispute. The amount or any expenses eligible for payment under this Section 6 during a calendar year will not affect the amount of
any expenses eligible for payment under this Section 6 in any other taxable year. In any such action brought by the Executive for damages or to enforce any provisions of this Agreement, the Executive shall be entitled to seek both legal and
equitable relief and remedies, including, without limitation, specific performance of the Company’s obligations hereunder, in his or her sole discretion. 

  
 7 

 7. Excise Tax Cut Back. 

(a) Anything in this Agreement to the contrary notwithstanding, if it shall be determined that any payment, distribution or benefit
provided (including, without limitation, the acceleration of any payment, distribution or benefit and the acceleration or exercisability of any stock option) to the Executive or for his or her benefit (whether paid or payable or distributed or
distributable) pursuant to the terms of this Agreement or otherwise would be subject, in whole or in part, to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the amounts payable to the Executive under
Section 4(ii) of this Agreement shall be reduced (by the minimum possible amount) until no amount payable to the Executive is subject to the Excise Tax; provided, however, that no such reduction shall be made if the net after-tax benefit
(after taking into account Federal, state, local or other income, employment, self-employment and excise taxes) to which the Executive would otherwise be entitled without such reduction would be greater than the net after-tax benefit (after taking
into account Federal, state, local or other income, employment, self-employment and excise taxes) to the Executive resulting from the receipt of such payments with such reduction. 

(b) All determinations required to be made under this Section 7, including whether a payment would result in an Excise Tax, shall be
made by PricewaterhouseCoopers LLP or, if PricewaterhouseCoopers LLP cannot or will not provide such services, another nationally recognized accounting firm acceptable to both parties (the “Accounting Firm”), which shall provide detailed
supporting calculations both to the Company and the Executive as requested by the Company or the Executive. All fees and expenses of the Accounting Firm shall be borne solely by the Company and shall be paid by the Company. All determinations made
by the Accounting Firm under this Section 7 shall be final and binding upon the Company and the Executive. 
 8.
Confidential Information. The Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its subsidiaries, and their respective
businesses, which shall have been obtained by the Executive during the Executive’s employment by the Company or any of its subsidiaries and which has not become public knowledge (other than by acts of the Executive or his or her representatives
in violation of this Agreement). After the date of termination of the Executive’s employment with the Company, the Executive shall not, without the prior written consent of the Company, communicate or divulge any such information, knowledge or
data to anyone other than the Company and those designated by it. In no event shall an asserted violation of the provisions of this Section 8 constitute a basis for deferring or withholding any amounts otherwise payable to the Executive under
this Agreement. 
 9. Successors. 
 (a) This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and
distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s heirs, executors, administrators, legal representatives or successor(s) in interest. 

  
 8 

 (b) This Agreement shall inure to the benefit of and be binding upon the Company and its
successors and assigns. 
 (c) The Company will require any successor (whether direct or indirect, by purchase, merger,
consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it
if no such succession had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by
operation of law or otherwise. 
 10. Section 409A. 

(a) It is intended that this Agreement will comply with Section 409A of the Code (and any regulations and guidelines issued
thereunder) to the extent the Agreement is subject thereto, and the Agreement shall be interpreted on a basis consistent with such intent. 
 (b) If an amendment of the Agreement is necessary in order for it to comply with Section 409A, the parties hereto will negotiate in good faith to amend the Agreement in a manner that preserves the
original intent of the parties to the extent reasonably possible. 
 (c) Notwithstanding any provision to the contrary in this
Agreement, if the Executive is deemed on the date of his or her “separation from service” (within the meaning of Treas. Reg. Section 1.409A-1(h)) to be a “specified employee” (within the meaning of Treas. Reg.
Section 1.409A-1(i)), then with regard to any payment that is required to be delayed pursuant to Section 409A(a)(2)(B) of the Code, such payment shall not be made prior to the earlier of (i) the expiration of the six (6)-month period
measured from the date of his or her “separation from service,” or (ii) the date of his or her death (the “Delay Period”). Upon the expiration of the Delay Period, all payments delayed pursuant to this Section 10
(whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid to the Executive in a lump sum, and any remaining payments due under this Agreement shall be paid in accordance with the
normal payment dates specified for them herein. 
 (d) Notwithstanding any provision of this Agreement to the contrary, for
purposes of Section 4 above, the Executive’s employment will be deemed to have terminated on the date of the Executive’s “separation from service” (within the meaning of Treas. Reg. Section 1.409A-1(h)) with the
Company. 
 (e) Wherever payments under this Agreement are to be made in installments, each such installment
shall be deemed to be a separate payment for purposes of Section 409A. For purposes of this Agreement, each payment is intended to be excepted from Section 409A to the maximum extent provided under Section 409A as follows:
(i) each payment that is scheduled to be made following the Executive’s termination date and within the applicable 2-1/2 month period specified in Treas. Reg. Section 1.409A-1(b)(4) (i.e., generally March 15th of the calendar
year following the calendar year in which the Executive terminated employment) is intended to be excepted under the short-term deferral exception as specified in Treas. Reg. Section 1.409A-1(b)(4), (ii) post-termination medical benefits
are intended to be excepted under 

  
 9 

 
the medical benefits exception as specified in Treas. Reg. Section 1.409A-1(b)(9)(v)(B), (iii) post-termination outplacement expenses are intended to be excepted under the outplacement
expenses exception specified in Treas. Reg. Section 1.409A-1(b)(9)(v)(A), and (iv) each payment that is not otherwise excepted under the short-term deferral exception, medical benefits exception or outplacement expenses exception is
intended to be excepted under the involuntary separation pay exception as specified in Treas. Reg. Section 1.409A-1(b)(9)(iii). 
 (f) With respect to any reimbursement or in-kind benefit arrangements of the Company and its subsidiaries provided for herein that constitute deferred compensation for purposes of Section 409A of the
Code, the following conditions shall be applicable: (i) the amount eligible for reimbursement, or in-kind benefits provided, under any such arrangement in one calendar year may not affect the amount eligible for reimbursement, or in-kind
benefits to be provided, under such arrangement in any other calendar year (except that the health and dental plans may impose a limit on the amount that may be reimbursed or paid if such limit is imposed on all participants), (ii) any
reimbursement must be made on or before the last day of the calendar year following the calendar year in which the expense was incurred, and (iii) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for
another benefit. 
 (g) No action or failure to act pursuant to this Section 10 shall subject the Company to any claim,
liability, or expense, and the Company shall not have any obligation to indemnify or otherwise protect the Executive from the obligation to pay any taxes pursuant to Section 409A of the Code. 

11. Miscellaneous. 
 (a) This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws thereof. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.

 (b) All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party
or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 If to
the Executive: 
 [Name and address] 

If to the Company: 
 Gentiva Health Services, Inc. 
 3350 Riverwood Parkway 

Suite 1400 
 Atlanta, GA 30339 
 Attention: Chief Executive Officer 

  
 10 

 or to such other address as either party shall have furnished to the other herewith. Notice and
communications shall be effective when actually received by the addressee. 
 (c) The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. 
 (d) The
Company may withhold from any amounts payable under this Agreement such Federal, state or local taxes as shall be required to be withheld pursuant to any applicable law or regulation. 

(e) The Executive’s failure to insist upon strict compliance with any provision hereof shall not be deemed to be a waiver of such
provision or any other provision thereof. 
 (f) This Agreement contains the entire understanding of the Company and the
Executive with respect to the subject matter hereof but, except as specifically provided in Section 4 hereof, does not supersede or override the provisions of (i) any stock option, employee benefit or other plan, program, policy or
practice in which Executive is a participant or under which the Executive is a beneficiary, (ii) the Severance Agreement dated as of
                             between the Executive and the Company and any successor severance
agreement or (iii) the Indemnification Agreement dated as of                              between
the Executive and the Company; provided, however, that this Agreement does supersede and replace any prior severance agreement (except the Severance Agreement identified in subdivision (ii) of this subsection (f) and any successor
severance agreement) and change in control agreements between the Company and the Executive. 
 [Next Page is Signature Page]

  
 11 

 IN WITNESS WHEREOF, the Executive has hereunto set his or her hand and, pursuant to the
authorization from its Board of Directors, the Company has caused these presents to be executed as of the day and year first above written. 
  

			
	  

	Name: [            ]
	
	GENTIVA HEALTH SERVICES, INC.
		
	By:	 	  

		 	Name: [            ]
		 	Title: [            ]

  
 12Form of Severance Agreement

 Exhibit 10.2 
 [Date] 
 [Name] 
 [Address] 
 Dear [Name]: 
 In consideration of the mutual promises, covenants and obligations contained herein, this Severance Agreement is entered into between you and Gentiva Health Services, Inc., a Delaware corporation (the
“Company”): 
  

	 	1.	(a) This Severance Agreement replaces in its entirety the Severance Agreement dated as of
                             between you and the Company, which is hereby terminated.

 (b) Your employment with the Company will be as an employee at will. Your status as an officer of the Company
will be determined by the Board of Directors of the Company in accordance with the By-Laws of the Company. 
  

	 	2.	Should the Company terminate your employment other than for cause (as hereinafter defined), you will be entitled to the following severance benefits, which are
expressly conditioned upon your compliance with the terms set forth in paragraph 4 of this Severance Agreement: 

 (a) The Company will pay to you an amount equal to the sum of: (i) your then current base salary, and (ii) your target annual bonus, if any, for the year that includes your termination of
employment, with such amount payable to you in substantially equal bi-weekly installments (or such other regular payroll cycle in use by the Company at the time your employment terminates) over the twelve (12) month period beginning on the day
following your termination of employment (the “Severance Period”); provided, however, that any amount otherwise payable to you prior to sixty (60) days after such termination of employment shall be paid, subject to paragraph 6
below, on the sixtieth (60th) day following your
termination of employment. 

 (b) The Company will pay to you, subject to paragraph 6 below, (i) any base salary
earned, accrued or owing to you through the date of your termination of employment, which will be paid in accordance with the standard payroll practices of the Company, (ii) any individual bonuses or individual incentive compensation not yet
paid, but due and payable under the Company’s plans or arrangements for years prior to the year of your termination of employment, which will be paid no later than the time such amounts are paid to active employees in accordance with the terms
of the applicable plans or arrangements, and (iii) base salary in lieu of any unused paid time off (“PTO”) in accordance with the Company’s general PTO policy, which will be paid ten (10) business days after the date of your
termination of employment. 
 (c) You will be entitled to a pro rata share of any individual annual cash incentive bonus or
individual annual cash incentive compensation under the Company’s plans or arrangements for the year of your termination of employment based on the portion of such year that you were employed by the Company; provided, however, that the payment
of the bonus or incentive compensation will continue to be subject to the attainment of performance goals as specified in the applicable plans or arrangements, which amounts, if any, would be paid no later than the time such amounts are paid to
active employees in accordance with the applicable terms of the plans or arrangements. 
 (d) Your
medical/prescription/dental/vision benefits will be continued until the end of the Severance Period or until similar benefits become available to you from a new employer, whichever comes first. Such benefits continuation shall be on the same basis
as if you had continued in the employ of the Company (e.g., including any required associate contributions) during that period adjusted for any plan changes. Any continuation of your medical/prescription/dental/vision benefits pursuant to
this subparagraph (d) will be deemed to run concurrently with the continuation period federally mandated by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), or any other legally mandated and applicable
federal, state, or local coverage period for benefits provided to terminated employees under a health care plan. 

  
 2 

 (e) You will be entitled to outplacement services with an outplacement firm of your choice
for up to twelve (12) months or until you obtain comparable employment (as determined by the Company), whichever is shorter; provided, however, that (i) you must select an outplacement firm and commence the outplacement services no more
than ninety (90) days following your termination of employment, (ii) such outplacement services must be reasonable and commensurate with your position with the Company (as determined by the Company), and (iii) in no event, will the
aggregate amount the Company incurs to provide such outplacement services exceed more than thirty thousand dollars ($30,000). 

For purposes of this Severance Agreement, the term “cause” shall mean the following: your conviction for any felony; any act of
willful fraud, dishonesty or moral turpitude; controlled substance abuse; abuse of alcohol or drugs which interferes with or affects your responsibilities to the Company or which reflects negatively upon the integrity or reputation of the Company;
gross negligence which is materially injurious to the Company; any violation of any express written directions or any reasonable written policy or procedure established by the Company from time to time regarding the conduct of its business; or any
violation by you of any material term and condition of this Severance Agreement. 
  

	 	3.	Upon a material reduction in your current base salary, as the same may be increased from time to time, which is not part of a general salary reduction for a majority of
salaried employees of the Company and to which you do not consent in writing, you will have the right (subject to the notice and cure provisions below) to resign and receive the severance benefits described above, with your severance payments based
on your salary prior to it having been reduced. In order to exercise this right you must have given written notice to the Company of the reduction in base salary within sixty (60) days after it is so reduced, and the Company must not have
remedied the base salary reduction within the thirty (30) day period after receipt of such written notice; provided further, however, that any termination of employment by you under this paragraph 3 must occur not later
than one (1) year following the initial existence of the base salary reduction giving rise to your right to terminate under this paragraph 3. 

  

	 	4.	 Should the Company terminate your employment other than for “cause” (as defined in paragraph 2 of this Severance Agreement) or should you
terminate your employment pursuant to paragraph 3 above, you also agree that your receipt of the severance payments and benefits provided for herein is expressly conditioned upon (i) your complying with the terms and conditions of the
applicable Executive Non-Solicitation, Non-Competition and Confidentiality Agreement between the Company and you, and (ii) your execution and delivery within fifty (50) days after termination of your employment of, and your failure to
revoke within the statutory revocation period, the General Release Agreement, the form of which is attached hereto as Exhibit A. You acknowledge and agree that the terms and conditions of the aforesaid Executive Non-Solicitation, Non-Competition

  
 3 

	 	 
and Confidentiality Agreement will remain in full force and effect after the termination of your employment for any reason even if you choose not to execute the aforesaid General Release
Agreement. You further acknowledge that, in the event that the Georgia Court of Appeals and/or the Georgia Supreme Court determines that O.C.G.A. 13-8-50 et seq. is valid or in the event that a statute similar to O.C.G.A. 13-8-50 et
seq. is passed into law in Georgia, the Company will require you to enter into a new and expanded Executive Non-Solicitation, Non-Competition and Confidentiality Agreement which will comport with the increased permissible scope of O.C.G.A.
13-8-50 et seq. or such similar statute that is passed into law in Georgia and that such new Executive Non-Solicitation, Non-Competition and Confidentiality Agreement will replace and supersede your existing agreement with the Company.

  

	 	5.	This Severance Agreement may be amended only by a written instrument signed by the Company and you. Except with respect to your Change in Control Agreement with the
Company, your Indemnification Agreement with the Company and any other agreement between the Company and you specifically referenced herein and intended to continue beyond the execution of this Severance Agreement, this Severance Agreement shall
constitute the entire agreement between the Company and you with respect to the subject matter hereof and supersedes any other severance or separation pay plan or policy that would otherwise apply to you. This Severance Agreement shall be governed
by the laws of the State of Georgia, without regard to the principles of conflict of laws thereof. This Severance Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, heirs (in your case)
and assigns. 

  

	 	6.	(a) It is intended that this Severance Agreement will comply with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) (and any
regulations and guidelines issued thereunder) to the extent the Severance Agreement is subject thereto, and the Severance Agreement shall be interpreted on a basis consistent with such intent. 

(b) If an amendment of the Severance Agreement is necessary in order for it to comply with Section 409A, the parties hereto will
negotiate in good faith to amend the Severance Agreement in a manner that preserves the original intent of the parties to the extent reasonably possible. 
 (c) Notwithstanding any provision to the contrary in this Severance Agreement, if you are deemed on the date of your “separation from service” (within the meaning of Treas. Reg.
Section 1.409A-1(h)) to be a “specified employee” (within the meaning of Treas. Reg. Section 1.409A-1(i)), then with regard to any payment that is required to be delayed pursuant to Section 409A(a)(2)(B) of the Code, such
payment shall not be made prior to the earlier of (i) the expiration of the six (6)-month period measured from the date of your “separation from service,” or (ii) the date of your death (the “Delay Period”). Upon the
expiration 

  
 4 

 
of the Delay Period, all payments delayed pursuant to this paragraph 6 (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be
paid to you in a lump sum, and any remaining payments due under this Severance Agreement shall be paid in accordance with the normal payment dates specified for them herein. 
 (d) Notwithstanding any provision of this Severance Agreement to the contrary, your employment will be deemed to have terminated on the date of your “separation from service” (within the meaning
of Treas. Reg. Section 1.409A-1(h)) with the Company. 
 (e) Wherever payments under this Severance Agreement are to be made
in installments, each such installment shall be deemed to be a separate payment for purposes of Section 409A. For purposes of this Severance Agreement, each payment is intended to be excepted from Section 409A to the maximum extent
provided under Section 409A as follows: (i) each payment that is scheduled to be made following your termination date and within the applicable 2-1/2 month period specified in Treas. Reg. Section 1.409A-1(b)(4) (i.e., generally
March 15th of the calendar year following the calendar year in which you terminated employment) is intended to be excepted under the short-term deferral exception as specified in Treas. Reg. Section 1.409A-1(b)(4);
(ii) post-termination medical benefits are intended to be excepted under the medical benefits exception as specified in Treas. Reg. Section 1.409A-1(b)(9)(v)(B); (iii) post-termination outplacement expenses are intended to be excepted
under the outplacement expenses exception specified in Treas. Reg. Section 1.409A-1(b)(9)(v)(A); and (iv) each payment that is not otherwise excepted under the short-term deferral exception, medical benefits exception or outplacement
expenses exception is intended to be excepted under the involuntary separation pay exception as specified in Treas. Reg. Section 1.409A-1(b)(9)(iii). 
 (f) With respect to any reimbursement or in-kind benefit arrangements of the Company provided for herein that constitute deferred compensation for purposes of Section 409A, the following conditions
will be applicable: (i) the amount eligible for reimbursement, or in-kind benefits provided, under any such arrangement in one calendar year may not affect the amount eligible for reimbursement, or in-kind benefits to be provided, under such
arrangement in any other calendar year (except that health and dental plans may impose a limit on the amount that may be reimbursed or paid if such limit is imposed on all participants), (ii) any reimbursement must be made on or before the last
day of the calendar year following the calendar year in which the expense was incurred, and (iii) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. 

(g) No action or failure to act, pursuant to this paragraph 6 shall subject the Company to any claim, liability, or expense, and the
Company shall not have any obligation to indemnify or otherwise protect you from the obligation to pay any taxes pursuant to Section 409A. 

  
 5 

											
	Sincerely,	 		 		 		 	
						
	By:	 	  
	 		 		 		 	
		 	[Name]	 		 		 		 	
		 	[Authorized Officer Title]	 		 		 		 	
					
	Agreed to and Accepted by:	 		 		 		 	
					
	  
	 		 	[                    ]	 		 	
	 [Name of Executive]
	 		 	Date	 		 	

  
 6 

 EXHIBIT A 
 GENERAL RELEASE 
 1) I, [Name of Executive], understand that, in order to receive the
severance package contained in Section 2 of the Severance Agreement between Gentiva Health Services, Inc. and me dated as of
                     (the “Severance Agreement”) which I would not otherwise receive or be entitled to, I have been requested to
sign this General Release. I further understand that by signing this General Release, I am waiving my right to raise any claims against Gentiva Health Services, Inc. (“Gentiva” or “the Company”) and other Releasees (as defined
below) under federal, state and/or local law. 
 2) General Release 

I hereby agree to release and forever discharge the Company, its subsidiaries and affiliates, and its and their directors and officers,
predecessors, employees, agents, successors and assigns (collectively “Releasees”) from any and all actions or causes of action, suits, claims, charges, complaints, contracts and promises whatsoever, in law or equity which I, my heirs,
assigns and any personal or legal representatives have or may have against any of the Releasees including all unknown, undisclosed and unanticipated losses, wrongs, injuries, debts, claims and/or damages arising out of or in any way connected with
my employment with the Company or its subsidiaries and the cessation of such employment. This shall include but not be limited to any alleged violation of Title VII of the Civil Rights Act of 1964, Section 1981 et seq. of
Title 42 of the United States Code, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Fair Labor Standards Act, the Occupational, Safety and
Health Act, Executive Law Section 290 et seq., each of the foregoing as amended, and any and all other Federal, State or local civil or human rights laws, or any other alleged violation of any local, State or Federal law,
regulation or ordinance, and/or public policy, contract or tort or common-law claim having any bearing whatsoever on the terms and conditions and/or cessation of my employment with the Company and its subsidiaries which I now have or shall have as
of the date of this General Release. 
 This General Release does not constitute a waiver of my right to bring action against
the Company to enforce the terms and provisions of the Severance Agreement. 
 This General Release does not constitute a waiver
of my prior indemnification rights, if any, should I be ordered to appear as a witness or made a defendant in any litigation regarding matters or actions taken within the scope of my responsibilities as an employee of the Company. 

 3) Not A Waiver of Vested Benefits 

This General Release shall not constitute a waiver of (i) my right to benefits which have vested on or prior to the date of
termination of my employment or the terms of any applicable employee benefit plan, or (ii) my unreimbursed business expenses properly incurred prior to the date my employment was terminated in accordance with Company policy. 

4) Covenant Not to Sue 

I agree that I will not file, charge (except that I may file a charge with the Equal Employment Opportunity Commission alleging age
discrimination), claim, sue or cause or permit to be filed any civil action, suit or legal proceeding seeking personal equitable or monetary relief for me in connection with any matter occurring at any time in the past concerning my employment
relationship with the Company, up to and including the date of this General Release, or involving any continuing effects of any acts or practices which may have arisen or occurred on or prior to the date of this General Release. I further agree that
should any person, organization, or other entity file, charge, claim, sue, or cause or permit to be filed any civil action, suit or legal proceeding involving any matter occurring at any time in the past, I will not seek or accept any personal
relief in such civil action, suit or legal proceeding. Nothing in this Section 4 shall limit my right to cooperate with the Equal Employment Opportunity Commission (“EEOC”) in an investigation of a charge of age discrimination,
including a charge filed with the EEOC filed by me. 
 5) Non-Disclosure of Terms 

I hereby agree that I shall not directly or indirectly publish the terms or conditions of this General Release nor discuss or make any
statements with regard to such terms or conditions except to my personal lawyer or as required by law. 
 6) Governing Law and
Interpretation 
 This General Release shall be governed by and construed in accordance with the laws of the State of
Georgia without regard to its conflict of laws provisions. Should any provision of this General Release be declared illegal or unenforceable by any court of competent jurisdiction, and cannot be modified to be enforceable, such provision shall
immediately become null and void, leaving the remainder of this General Release in full force and effect. However, if the release portion is held invalid or unenforceable by a court of competent jurisdiction or any governmental agency, or I exercise
my right to revoke as set forth in Section 8 below, then I agree to immediately return to the Company any payment I received as part of the severance package and the Company shall have no further obligation under the Severance Agreement.

 7) Entire Agreement; Amendment 
 This General Release, the Severance Agreement, the applicable Indemnification Agreement and the applicable Executive Non-Solicitation, Non-Competition and Confidentiality

  
 -2-

 
Agreement set forth the entire agreement between the parties hereto and shall supersede any and all prior understandings between the parties, except to the extent as set forth in the Severance
Agreement. This General Release may not be amended except by a written agreement signed by both parties to the Severance Agreement. 
 8)
Effective Date; Right to Revoke 
 I understand that I have been provided the opportunity to review this General Release
for a period of twenty-one (21) days. I understand that this General Release shall not become effective or enforceable until the expiration of seven (7) days following the date on which I first execute this General Release. I also
understand that I have the right to revoke this General Release within seven (7) days of when I sign this General Release and that such revocation shall not be effective unless each of the following conditions has been met: 

(a) the revocation is made in writing addressed to the Company and includes the statement, “I hereby revoke my agreement to the
General Release and the terms and conditions set forth in the Severance Agreement.” 
 (b) such written revocation is
delivered either by hand to the office of the General Counsel of Gentiva Health Services, Inc. or by mail with a postmark dated before the end of the seven (7) day revocation period, such mail to be certified, return receipt requested.

 I HAVE READ AND CONSIDERED THE TERMS AND CONDITIONS CONTAINED IN THIS GENERAL RELEASE. I UNDERSTAND THAT MY RIGHT TO RECEIVE THE SEVERANCE
PACKAGE IN ACCORDANCE WITH THE SEVERANCE AGREEMENT IS SUBJECT TO THE TERMS AND CONDITIONS SET FORTH IN THIS GENERAL RELEASE AND THAT I WOULD NOT RECEIVE SUCH BENEFITS BUT FOR MY EXECUTION OF THIS GENERAL RELEASE. I ALSO UNDERSTAND THAT BY EXECUTING
THIS GENERAL RELEASE, I WILL BE WAIVING MY RIGHTS UNDER FEDERAL, STATE AND LOCAL LAW TO BRING ANY CLAIMS THAT I HAVE OR MIGHT HAVE AGAINST ANY RELEASEES (AS DEFINED ABOVE). I HAVE BEEN AFFORDED AT LEAST TWENTY-ONE (21) DAYS TO CONSIDER THIS
GENERAL RELEASE AND HAVE BEEN ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO EXECUTING THIS GENERAL RELEASE. 
 IN
WITNESS WHEREOF, I have executed this General Release as of the date set forth below. 
  

			
	Signed:	 	  

		
	Date:	 	  

  
 -3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]